• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
S66
Click for more information
0.00% 15.0¢

STAR COMBO PHARMA LIMITED - Corporate Spotlight

Market Cap $20.26M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Household & Personal Products

Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the... Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the manufacture and distribution of health and natural beauty products. The Company operates through two segments: Star Combo business and Austoyou retail. The Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment is made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd and Star Combo Australia Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
15.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.26M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 31268 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 10000 1
View Market Depth
Last trade - 16.12pm 23/08/2024 (20 minute delay) ?
S66 (ASX) Chart

Top Stories

The business of sport: Warren Tredrea's take on this week's news

Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.